Kristen K Ciombor

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Ahmed Kamel, Howard S Hochster, Christopher G Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.

Afsaneh Barzi, Katrina Pedersen, Jeannine S McCune, 2019, The Lancet. Oncology.